JNJ-0966 – 10 mg

Brand:
Cayman
CAS:
315705-75-0
Storage:
-20
UN-No:
Non-Hazardous - /

JNJ-0966 is an inhibitor of matrix metalloproteinase-9 (MMP-9) zymogen activation (IC50 = 440 nM).{54517} It is selective for MMP-9 over MMP-1, MMP-2, and MMP-3 zymogen activation at 10 μM and does not inhibit the catalytic activity of MMP-1, -2, -3, -9, or -14. It inhibits invasion of HT-1080 cells in a MatrigelTM assay (IC50 = 1 μM). JNJ-0966 (10 and 30 mg/kg, twice per day) reduces disease severity in a mouse model of experimental autoimmune encephalomyelitis (EAE).  

 

Available on backorder

SKU: 31781 - 10 mg Category:

Description

An inhibitor of MMP-9 zymogen activation (IC50 = 440 nM); selective for MMP-9 over MMP-1, MMP-2, and MMP-3 zymogen activation at 10 μM; inhibits invasion of HT-1080 cells in a MatrigelTM assay (IC50 = 1 μM); reduces disease severity in a mouse model of EAE at 10 and 30 mg/kg, twice per day


Formal name: N-[2-[(2-methoxyphenyl)amino]-4′-methyl[4,5′-bithiazol]-2′-yl]-acetamide

Synonyms: 

Molecular weight: 360.5

CAS: 315705-75-0

Purity: ≥98%

Formulation: A crystalline solid